Related Experiment Videos
Meningeal hemangiopericytoma in childhood
T A Huisman1, S Brandner, F Niggli
1Department of Diagnostic Imaging and Radiology, University Children's Hospital Zurich, Switzerland.
Abstract:
Meningeal hemangiopericytoma (MHP) is extremely rare in childhood. Mean age at diagnosis is between 38 and 43 years. We present an 8-year-old boy with MHP of the middle cranial fossa. Imaging findings were indistinguishable from an aggressive bone tumor such as Ewing's sarcoma. Imaging findings are presented and discussed. Our case indicates that MHP should be considered in the differential diagnosis of skull-base tumors despite the fact that MHP is extremely rare in childhood.
Insights
Meningeal hemangiopericytoma (MHP) is rare in children, typically diagnosed in adulthood. This case highlights MHP in an 8-year-old, emphasizing its consideration in pediatric skull-base tumor diagnoses.
Area of Science:
- Neuro-oncology
- Pediatric oncology
- Skull base surgery
Background:
- Meningeal hemangiopericytoma (MHP) is a rare dural-based tumor, with a mean age at diagnosis typically between 38 and 43 years.
- Childhood MHP is exceptionally uncommon, posing diagnostic challenges due to its rarity.
Observation:
- An 8-year-old boy presented with a middle cranial fossa mass.
- Initial imaging findings mimicked aggressive bone tumors like Ewing's sarcoma.
Findings:
- The case demonstrates that imaging characteristics of MHP can resemble other aggressive pediatric skull-base tumors.
- Histopathological confirmation is crucial for accurate diagnosis.
Implications:
- Pediatric neuro-oncology should consider MHP in the differential diagnosis of skull-base lesions, even in young patients.
- This case underscores the importance of comprehensive diagnostic evaluation for rare pediatric tumors.